Advertisement

Topics

Medpace Holdings, Inc. Company Profile

03:48 EDT 19th June 2019 | BioPortfolio

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries.


News Articles [553 Associated News Articles listed on BioPortfolio]

Why a Long-Term View for Medpace Stock Is Bullish

Medpace Weakness Means Opportunity A small-cap healthcare stock with high prospects is Medpace Holdings Inc (NASDAQ:MEDP), a provider of third-party services to the pharmaceutical and medical devic...

Medpace Holdings Set to Join S&P SmallCap 600

NEW YORK, Dec. 21, 2018 /PRNewswire/ -- Medpace Holdings Inc. (NASD: MEDP) will replace Green Bancorp Inc. (NASD: GNBC) in the S&P SmallCap 600 effective prior to the open of trading on Wednesday, ...

Medpace Holdings Set to Join S P SmallCap 600

NEW YORK, Dec. 21, 2018 /PRNewswire/ -- Medpace Holdings Inc. (NASD: MEDP) will replace Green Bancorp Inc. (NASD: GNBC) in the S&P SmallCap 600 effective Read more...

Medpace Holdings, Inc. to Present at Jefferies 2019 Healthcare Conference

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in June: Jefferies 2019 Healthcare Confere...

Medpace Holdings, Inc. 2019 Q1 - Results - Earnings Call Slides

Medpace Holdings 2018 Q4 - Results - Earnings Call Slides

Medpace Holdings, Inc. to Report First Quarter 2019 Financial Results on April 29, 2019

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2019 financial results after the market close on Monday, April 29, 2019...

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2018 Financial Results on February 25, 2019

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2018 financial results after the market close on Monda...

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Six-Year Prospective Outcomes of Primary Breast Augmentation With Nano Surface Implants.

Motiva Implants (Establishment Labs Holdings Inc.) are a novel family of silicone breast implants using cutting-edge technologies engineered to optimize aesthetic and safety outcomes.

Spreading dynamics in a cattle trade network: Size, speed, typical profile and consequences on epidemic control strategies.

Infections can spread among livestock notably because infected animals can be brought to uncontaminated holdings, therefore exposing a new group of susceptible animals to the disease. As a consequence...

Early clinical results with the Tendyne transcatheter mitral valve replacement system.

Transcatheter mitral valve replacement is an emerging technology for the treatment of mitral valve regurgitation. Numerous devices are in development and in various stages of clinical investigation. T...

Four years of African swine fever in Poland. New insights into epidemiology and prognosis of future disease spread.

Four and a half years of African Swine Fever (ASF) in population of free-ranging wild boars and domestic pigs revealed a number of novel insights into the disease epidemiology. Until No- vember 20th, ...

A survey of digitized data from U.S. fish collections in the iDigBio data aggregator.

Recent changes in institutional cyberinfrastructure and collections data storage methods have dramatically improved accessibility of specimen-based data through the use of digital databases and data a...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease

To afford urgent access to a potential-disease modifying treatment, Dr. Diana Kerwin, in partnership with CTD Holdings, the manufacturer of Trappsol (R) Cyclo(TM), will administer the prod...

Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann-Pick disease Type C1 (NPC-1) is safe at 3 different dose l...

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann Pick disease Type C (NPC-1) is safe at 2 different dose le...

Frequent Fallers' Experiences of an Adapted Walking Frame, Designed to Reduce the Walking Aid's Associated Falls Risk

For some patients with mobility issues, a walking frame (commonly known as a zimmer frame - trademark of Zimmer Holdings), is provided to keep them on their feet and help them remain more ...

Companies [490 Associated Companies listed on BioPortfolio]

Medpace Holdings, Inc.

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pha...

Medpace, Inc.

Established in 1992, Medpace has partnered with leading pharmaceutical and biotech companies to bring promising new drugs to market. Medpace combines efficient clinical trial management with comprehen...

Medpace

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

Sabre Holdings

Sabre Holdings connects people with the world's greatest travel possibilities by retailing travel products and providing distribution and technology solutions for the travel indus...

More Information about "Medpace Holdings, Inc." on BioPortfolio

We have published hundreds of Medpace Holdings, Inc. news stories on BioPortfolio along with dozens of Medpace Holdings, Inc. Clinical Trials and PubMed Articles about Medpace Holdings, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medpace Holdings, Inc. Companies in our database. You can also find out about relevant Medpace Holdings, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record